Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magd Zakaria

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|November 3, 2022
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year inMaura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in EgyptMagd Zakaria, Dina A Zamzam, Mohamed A Abdel Hafeez, et al.
Neurology. Clinical Practice|June 26, 2026
Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and OpportunityAndrew J Solomon, Magd Zakaria, Deanna R Saylor, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 21, 2019
Clinical Characteristics of Borderzone Infarction in Egyptian PopulationNevine El Nahas, Hossam Shokri, Osama Abdulghani, et al.
Clinical Neurology and Neurosurgery|March 14, 2021
Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)Raed Alroughani, Zuhair AlKawi, Ahmed Hassan, et al.
Neurology and Therapy|April 17, 2020
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative ReviewIsa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Journal of the Neurological Sciences|January 22, 2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist InterviewsSofie Aerts, Lotte Geys, Deborah Severijns, et al.
Multiple Sclerosis and Related Disorders|October 17, 2021
The MuSC-19 study: The Egyptian cohortMagd Zakaria, Marta Ponzano, Irene Schiavetti, et al.
CNS Drugs|January 27, 2026
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS GuidelinesBassem Yamout, Riadh Gouider, Raed Al-Roughani, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|November 3, 2022
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year inMaura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in EgyptMagd Zakaria, Dina A Zamzam, Mohamed A Abdel Hafeez, et al.
Neurology. Clinical Practice|June 26, 2026
Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and OpportunityAndrew J Solomon, Magd Zakaria, Deanna R Saylor, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 21, 2019
Clinical Characteristics of Borderzone Infarction in Egyptian PopulationNevine El Nahas, Hossam Shokri, Osama Abdulghani, et al.
Clinical Neurology and Neurosurgery|March 14, 2021
Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)Raed Alroughani, Zuhair AlKawi, Ahmed Hassan, et al.
Neurology and Therapy|April 17, 2020
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative ReviewIsa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Journal of the Neurological Sciences|January 22, 2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist InterviewsSofie Aerts, Lotte Geys, Deborah Severijns, et al.
Multiple Sclerosis and Related Disorders|October 17, 2021
The MuSC-19 study: The Egyptian cohortMagd Zakaria, Marta Ponzano, Irene Schiavetti, et al.
CNS Drugs|January 27, 2026
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS GuidelinesBassem Yamout, Riadh Gouider, Raed Al-Roughani, et al.
Pageof 3